Cathy A. Finlay

10.6k total citations · 5 hit papers
25 papers, 8.9k citations indexed

About

Cathy A. Finlay is a scholar working on Oncology, Genetics and Molecular Biology. According to data from OpenAlex, Cathy A. Finlay has authored 25 papers receiving a total of 8.9k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Oncology, 12 papers in Genetics and 11 papers in Molecular Biology. Recurrent topics in Cathy A. Finlay's work include Cancer-related Molecular Pathways (13 papers), Cancer Research and Treatments (10 papers) and Virus-based gene therapy research (9 papers). Cathy A. Finlay is often cited by papers focused on Cancer-related Molecular Pathways (13 papers), Cancer Research and Treatments (10 papers) and Virus-based gene therapy research (9 papers). Cathy A. Finlay collaborates with scholars based in United States, France and Israel. Cathy A. Finlay's co-authors include Arnold J. Levine, Jamil Momand, Philip W. Hinds, Tse‐Hua Tan, Moshe Oren, Daniel Eliyahu, Dirk P. Dittmer, Gerard P. Zambetti, Mary Moore and Angelika K. Teresky and has published in prestigious journals such as Nature, Cell and Nature Genetics.

In The Last Decade

Cathy A. Finlay

25 papers receiving 8.7k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The p53 tumour suppressor gene

1991 3.3k citations Arnold J. Levine, Jamil Momand et al. Nature profile →
The p53 proto-oncogene can act as a suppressor of transformation

1989 1.6k citations Cathy A. Finlay, Philip W. Hinds et al. Cell profile →
Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.

1988 1.0k citations Cathy A. Finlay, Philip W. Hinds et al. Molecular and Cellular Biology profile →
Gain of function mutations in p53

1993 728 citations Dirk P. Dittmer, Gerard P. Zambetti et al. Nature Genetics profile →
Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation

1989 499 citations Philip W. Hinds, Cathy A. Finlay et al. Journal of Virology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Cathy A. Finlay United States	17	6.6k	4.8k	1.8k	1.8k	1.1k	25	8.9k
Richard Iggo Switzerland	42	4.6k 0.7×	4.8k 1.0×	900 0.5×	2.0k 1.1×	1.3k 1.3×	95	8.2k
S E Kern United States	38	5.6k 0.8×	4.4k 0.9×	590 0.3×	3.1k 1.7×	681 0.6×	51	8.5k
Farideh Z. Bischoff United States	35	3.4k 0.5×	3.1k 0.7×	612 0.3×	1.8k 1.0×	1.3k 1.2×	91	7.1k
Julian Gannon United Kingdom	30	3.4k 0.5×	4.0k 0.8×	741 0.4×	829 0.5×	687 0.6×	54	6.2k
Richard A. Ashmun United States	30	4.5k 0.7×	5.9k 1.2×	530 0.3×	917 0.5×	811 0.8×	53	8.4k
Jun Yokota Japan	51	3.3k 0.5×	4.6k 1.0×	299 0.2×	2.0k 1.1×	894 0.8×	140	8.3k
Piero Dalerba United States	26	7.4k 1.1×	6.7k 1.4×	767 0.4×	3.6k 2.0×	688 0.7×	47	11.8k
Beverly Plunkett United States	18	3.7k 0.6×	3.8k 0.8×	1.0k 0.6×	1.0k 0.6×	419 0.4×	22	5.9k
Betty L. Slagle United States	33	3.4k 0.5×	4.0k 0.8×	847 0.5×	1.3k 0.7×	635 0.6×	54	6.7k
Helene S. Smith United States	41	2.9k 0.4×	3.5k 0.7×	265 0.1×	2.2k 1.2×	1.7k 1.6×	91	6.8k

Countries citing papers authored by Cathy A. Finlay

Since Specialization

Citations

This map shows the geographic impact of Cathy A. Finlay's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cathy A. Finlay with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cathy A. Finlay more than expected).

Fields of papers citing papers by Cathy A. Finlay

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cathy A. Finlay. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cathy A. Finlay. The network helps show where Cathy A. Finlay may publish in the future.

Co-authorship network of co-authors of Cathy A. Finlay

This figure shows the co-authorship network connecting the top 25 collaborators of Cathy A. Finlay. A scholar is included among the top collaborators of Cathy A. Finlay based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cathy A. Finlay. Cathy A. Finlay is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Laffitte, Bryan, et al.. (2004). A Novel System for Automated RNA Isolation: Increasing Throughput without Increasing Footprint. JALA Journal of the Association for Laboratory Automation. 9(3). 146–149. 2 indexed citations

Siu, Amy, et al.. (2003). Work-Cell Approach to Automating High Content Screening. JALA Journal of the Association for Laboratory Automation. 8(2). 66–67. 1 indexed citations

Lundgren, Karen, Rosa Luna, Brian Spencer, et al.. (1997). Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53.. Genes & Development. 11(6). 714–725. 215 indexed citations

Luna, Roberto Montes de Oca, Heidi Eberspaecher, Diana L. Hulboy, et al.. (1996). The Organization and Expression of themdm2Gene. Genomics. 33(3). 352–357. 41 indexed citations

Finlay, Cathy A.. (1995). [39] Rat embryo fibroblast complementation assay with ras genes. Methods in enzymology on CD-ROM/Methods in enzymology. 255. 389–394. 4 indexed citations

Finlay, Cathy A.. (1993). The mdm-2 Oncogene Can Overcome Wild-Type p53 Suppression of Transformed Cell Growth. Molecular and Cellular Biology. 13(1). 301–306. 81 indexed citations

Dittmer, Dirk P., Gerard P. Zambetti, Angelika K. Teresky, et al.. (1993). Gain of function mutations in p53. Nature Genetics. 4(1). 42–46. 728 indexed citations breakdown →

Finlay, Cathy A.. (1993). Normal and malignant growth control by p53. Cancer treatment and research. 63. 327–344. 13 indexed citations

Finlay, Cathy A.. (1993). The mdm-2 oncogene can overcome wild-type p53 suppression of transformed cell growth.. Molecular and Cellular Biology. 13(1). 301–306. 274 indexed citations

10.

Finlay, Cathy A.. (1992). What the papers say: p53 Loss of Function: Implications for the Processes of Immortalization and Tumorigenesis. BioEssays. 14(8). 557–560. 21 indexed citations

11.

Levine, Arnold J., Jamil Momand, & Cathy A. Finlay. (1991). The p53 tumour suppressor gene. Nature. 351(6326). 453–456. 3311 indexed citations breakdown →

12.

Zambetti, Gerard P., Robin S. Quartin, Jean Martínez, et al.. (1991). Regulation of Transformation and the Cell Cycle by p53. Cold Spring Harbor Symposia on Quantitative Biology. 56(0). 219–225. 8 indexed citations

13.

Hinds, Philip W., Cathy A. Finlay, Robin S. Quartin, et al.. (1990). Mutant p53 DNA clones from human colon carcinomas cooperate with ras in transforming primary rat cells: a comparison of the "hot spot" mutant phenotypes.. PubMed. 1(12). 571–80. 366 indexed citations

14.

Finlay, Cathy A., et al.. (1989). The p53 proto-oncogene can act as a suppressor of transformation. Cell. 57(7). 1083–1093. 1627 indexed citations breakdown →

15.

Hinds, Philip W., Cathy A. Finlay, & Arnold J. Levine. (1989). Mutation is required to activate the p53 gene for cooperation with the ras oncogene and transformation. Journal of Virology. 63(2). 739–746. 499 indexed citations breakdown →

16.

Finlay, Cathy A., Philip W. Hinds, Tse‐Hua Tan, et al.. (1988). Activating Mutations for Transformation by p53 Produce a Gene Product That Forms an hsc70-p53 Complex with an Altered Half-Life. Molecular and Cellular Biology. 8(2). 531–539. 283 indexed citations

17.

Finlay, Cathy A., Philip W. Hinds, Tse‐Hua Tan, et al.. (1988). Activating mutations for transformation by p53 produce a gene product that forms an hsc70-p53 complex with an altered half-life.. Molecular and Cellular Biology. 8(2). 531–539. 1015 indexed citations breakdown →

18.

Finlay, Cathy A. & Vincent J. Cristofalo. (1987). Autocrine stimulation of WI38 cell proliferation in the presence of glucocorticoids. Experimental Cell Research. 168(1). 191–202. 11 indexed citations

19.

Finlay, Cathy A., Bernard Rosner, Jeffrey B. Miller, John L. Wallace, & Vincent J. Cristofalo. (1985). Enhanced proliferation of WI38 cells in the presence of glucocorticoid-conditioned medium. Experimental Cell Research. 156(2). 462–470. 12 indexed citations

20.

Dyke, Terry Van, Cathy A. Finlay, & Ariel J. Levine. (1985). A Comparison of Several Lines of Transgenic Mice Containing the SV40 Early Genes. Cold Spring Harbor Symposia on Quantitative Biology. 50(0). 671–678. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact